Bavarian Nordic Discloses Share Buyback Transactions Under DKK 250M Program
Bavarian Nordic reports transactions under its share repurchase program running September through October 2026, capped at DKK 250 million.
Bavarian Nordic A/S disclosed transactions carried out under its ongoing share buyback program, the Danish biotech company announced Oct. 5, 2026. The repurchase initiative, which was launched Sept. 1, 2026, authorizes the company to buy back shares worth up to DKK 250 million before the program concludes Oct. 30, 2026.
The Copenhagen-based vaccine maker, listed on the Nasdaq Copenhagen exchange under the ticker BAVA, is conducting the buyback in compliance with European Union market abuse regulations. Specifically, the program operates within the framework established by EU Market Abuse Regulation No. 596/2014 and the accompanying delegated regulation EU No. 2016/1052, provisions collectively known as the Safe Harbour rules.
Read more Lotus Tech to Appear at WasabiCard Stablecoin Payments Event in Singapore →
Safe Harbour regulations are designed to protect companies executing structured buyback programs from allegations of insider trading or market manipulation, provided the repurchases are carried out according to strict procedural conditions. The rules require periodic public disclosure of individual transactions, which Bavarian Nordic is fulfilling with this announcement.
Share repurchase programs of this nature are commonly used by publicly traded companies to return capital to shareholders and can signal management's confidence in the company's financial position. Bavarian Nordic's program is set to run for a total of two months, with the buyback window closing at the end of October 2026.
Continue reading at GlobeNewswire - Industry News on Financial Services.
